NightWatch arives in the USA!

Pre-order now for priority access

  • Be among the very first to use the FDA-cleared NightWatch+ Seizure Detection, designed for the US market.
  • Market introduction planned for January 2026.
  • NightWatch+ is a prescription-only medical device (a valid prescription from a licensed healthcare provider is needed before we can ship your device).
  • There is no need to pay now; we will contact you as soon as production begins.

NightWatch+ for the U.S.

Access Europe’s leading technology solution to detect seizures during sleep at home.

The U.S. version of NightWatch+ is an FDA-cleared, prescription-only medical device. It is authorized for use in children aged 4 to 16 years and is designed to detect and alert caregivers to nocturnal epileptic motor seizures that may be associated with an increased risk of injury, including SUDEP (Sudden Unexpected Death in Epilepsy).

Nocturnal seizures are seizures during sleep. Motor seizures are epileptic seizures involving muscles in any way, which can be sudden stiffness, jerking of the muscles, or leg pedalling movements. NightWatch+ detects the following seizure types:

  • Tonic-Clonic (TC)
  • Tonic (if clustered or prolonged >30 seconds)
  • Hyperkinetic
  • TC-like seizures

Plug and Play Peace of Mind

NightWatch+ detects seizures straight out of the box and does not require a subscription or a mobile phone connection to work. Optionally, it connects to an online data portal to keep track of recordings over time.

I would like to order

The cost of NightWatch+ is $1,990 for home use and $2,290 for professional use; however, you don’t have to pay now. The U.S. launch team will contact you as soon as production begins to arrange delivery and onboarding.

Register now